Treatment of familial exudative vitreoretinopathy by inhibition of S1PR2

• 1. 一种鉴定家族性渗出性玻璃体视网膜病变的引物、试剂、试剂盒、方法及其应用 [P] . 中国专利： CN111500703B . 2021.01.08
• 2. 鉴定家族性渗出性玻璃体视网膜病变伴/不伴小头畸形的引物及其应用 [P] . 中国专利： CN112795642A . 2021-05-14
• 3. Treatment of familial exudative vitreoretinopathy by inhibition of S1PR2 [P] . JP6867165B2 . 2021-04-28

  机译： S1PR2抑制治疗家族性渗透性玻璃体病变

• 4. Treatment of familial exudative vitreoretinopathy by inhibition of s1pr2 [P] . 日本专利： JP2020114870A . 2020.07.30
• 5. Treatment of familial exudative vitreoretinopathy through S1PR2 inhibition [P] . AU2015271605B2 . 2019-11-14

  机译： 通过抑制S1PR2治疗家族性渗出性玻璃体视网膜病变

• 1. Clinical Analysis of Erzhi Mingmu Decoction in the Treatment of Non-exudative Age-related Macular Degeneration [J] . 姜艳华, 李若溪, 齐飞 世界中西医结合杂志（英文） . 2018,第004期
• 2. Clinical Analysis of Erzhi Mingmu Decoction in the Treatment of Non-exudative Age-related Macular Degeneration [J] . Jiang Yanhua, Li Ruoxi, Qi Fei 世界中西医结合杂志（英文） . 2018,第004期
• 3. Clinical Analysis of Erzhi Mingmu Decoction in the Treatment of Non-exudative Age-related Macular Degeneration [J] . 姜艳华, 李若溪, 齐飞 世界中西医结合杂志（英文） . 2018,第004期
• 4. Surgical treatments for fibrous tissue extending to the posterior retina in eyes with familial exudative vitreoretinopathy [J] . Takahashi Mari, Yokoi Tadashi, Katagiri Satoshi, Japanese Journal of Ophthalmology . 2018,第1期
• 5. The role of intravitreal ranubizumab in the treatment of familial exudative vitreoretinopathy of stage 2 or greater [J] . Yue-Zhu Lu1, Guang-Da Deng2, Jing-Hua Liu2, 国际眼科杂志：英文版 . 2018,第006期
• 6. Treatment of vascularly active familial exudative vitreoretinopathy with pegaptanib sodium (Macugen). [J] . Quiram PA, Drenser KA, Lai MM, Retina . 2008,第3Suppla期
• 7. The Effect of Processing and Treatment Parameters on the Discolouration of Painted Joinery Due to Resin Exudation from Knots [C] . Ralph Nussbaum Conference on Woodcoatings: Foundations for the Future Oct 28-30, 2002 The Hague, The Netherlands . 2002
• 8. Understanding Familial Risk Factors in Adolescents Seeking Substance Use Treatment [D] . Miller, Ellie. 2021
• 9. The role of intravitreal ranubizumab in the treatment of familial exudative vitreoretinopathy of stage 2 or greater [O] . Yue-Zhu Lu, Guang-Da Deng, Jing-Hua Liu, 2018
• 10. Analysis of Predisposing Clinical Features for Worsening Traction After Treatment of Familial Exudative Vitreoretinopathy in Children [O] . G. Baker Hubbard, Alexa L. Li 2021
• 11. Exudation Test for TNT Explosives under Confinement: Exudation Control and Proposed Standards. [R] . Voigt, H. W. 1983

• 1. Treatment of Crohn's disease and familial Mediterranean fever by leukopheresis:Single shot for two targets [J] . Mahmut Yuksel ,Fatih Saygili ,Orhan Coskun . 世界胃肠病学杂志：英文版 . 2015,第13期
• 2. Familial versus Sporadic Breast Cancer: Different Treatments for Similar Tumors? [J] . Ellen G. Engelhardt ,Mieke Kriege ,Maartje J. Hooning . 乳腺癌（英文） . 2015,第4期
• 3. 家族性渗出性玻璃体视网膜病变的诊断和鉴别诊断 [C] . 赵培泉 . 《中华眼科杂志》第三届中华眼科中青年论坛 . 2011
• 4. 家族性渗出性玻璃体视网膜病变患者基因突变的研究 [A] . 袁叶 . 2020